Current position:Home >Product >
Glycinamide,N-(mercaptoacetyl)-D-tyrosyl-4-(aminoiminomethyl)-L-phenylalanylglycyl-L-a-aspartyl-L-cysteinyl-L-lysylglycyl-L-cysteinyl-,cyclic (1®5)-thioether, (8®1''),(8'®1'')-bis(thioether) withN6-[N2,N6-bis(mercaptoacetyl)-L-lysyl]-L-lysylglycyl-L-cysteinamide (9CI)
Glycinamide,N-(mercaptoacetyl)-D-tyrosyl-4-(aminoiminomethyl)-L-phenylalanylglycyl-L-a-aspartyl-L-cysteinyl-L-lysylglycyl-L-cysteinyl-,cyclic (1®5)-thioether, (8®1''),(8'®1'')-bis(thioether) withN6-[N2,N6-bis(mercaptoacetyl)-L-lysyl]-L-lysylglycyl-L-cysteinamide (9CI)(167479-84-7)
- Name: Glycinamide,N-(mercaptoacetyl)-D-tyrosyl-4-(aminoiminomethyl)-L-phenylalanylglycyl-L-a-aspartyl-L-cysteinyl-L-lysylglycyl-L-cysteinyl-,cyclic (1®5)-thioether, (8®1''),(8'®1'')-bis(thioether) withN6-[N2,N6-bis(mercaptoacetyl)-L-lysyl]-L-lysylglycyl-L-cysteinamide (9CI)
- Synonyms:Glycinamide,N-(mercaptoacetyl)-D-tyrosyl-4-(aminoiminomethyl)-L-phenylalanylglycyl-L-a-aspartyl-L-cysteinyl-L-lysylglycyl-L-cysteinyl-,cyclic (1®5)-sulfide, (8®1''),(8'®1'')-bis(sulfide) withN6-[N2,N6-bis(mercaptoacetyl)-L-lysyl]-L-lysylglycyl-L-cysteinamide; P 748
- Molecular Formula:C107H153 N33 O32 S5
- Molecular Weight:
- CAS Registry Number:167479-84-7
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 7597-69-5/methyl [2-(acetylamino)-1-benzothiophen-3-yl]acetate
- 26547-31-9/2-[(4-chlorophenyl)sulfanyl]pyrimidine
- 172617-98-0/Stelladelin A (9CI)
- 91671-76-0/Iron,5,6-diamino-1,3-naphthalenedisulfonate complexes
- 68867-60-7/2-Propenoic acid, 2-(((heptadecafluorooctyl)sulfonyl)methylamino)ethyl ester, polymer with 2-(methyl((nonafluorobutyl)sulfonyl)amino)ethyl 2-propenoate, 2-(methyl((pentadecafluoroheptyl)sulfonyl)amino)ethyl 2-propenoate, 2-(methyl((tridecafluorohexyl)sulfonyl)amino)ethyl 2-propenoate, 2-(methyl((undecafluoropentyl)sulfonyl)amino)ethyl 2-propenoate and alpha-(1-oxo-2-propenyl)-omega-methoxypoly(oxy-1,2-ethanediyl)
- 162413-59-4/5,12-Naphthacenedione,7,10-bis[[O-2,6-dideoxy-a-L-lyxo-hexopyranosyl-(1®4)-O-2,6-dideoxy-a-L-lyxo-hexopyranosyl-(1®4)-2,3,6-trideoxy-3-(dimethylamino)-a-L-lyxo-hexopyranosyl]oxy]-8-ethyl-7,8,9,10-tetrahydro-1,6,8,11-tetrahydroxy-,(7R,8R,10S)- (9CI)
- 85797-09-7/N-cyclobutyl-3,4,5-trimethoxybenzamide
- 339-59-3/4-(TRIFLUOROMETHYL)BENZHYDRAZIDE
- 72176-80-8/3-(4-NITRO-PHENYL)-2-THIOXO-2,3-DIHYDRO-1H-QUINAZOLIN-4-ONE
- 10163-91-4/(3beta,17beta)-17-(1H-pyrazol-5-yl)androst-5-en-3-ol
- 89583-52-8/azepan-1-ylphosphonic dichloride
- 133577-33-0/2’-Epi Docetaxel
- 86368-44-7/1-tert-butyl-2,3-dichloro-4-methylbenzene
- 36168-42-0/ethyl 4,4-dimethyl-2-oxocyclohexanecarboxylate
- 1590-02-9/2-METHYLPROPANE TRICARBOXYLIC ACID
- 51022-76-5/Sulnidazole
- 5458-46-8/diethyl 2-acetamido-2-[[3-[(4-methylphenyl)sulfonylamino]phenyl]methyl ]propanedioate
- 93349-90-7/5-bromo-8-methoxy-1,2,3,4-tetrahydronaphthalene-2-carboxylic acid
- 569-04-0/(+)-1,8-Dihydroxy-3-(2-hydroxypropyl)-6-methoxy-9,10-anthracenedione
- 167479-84-7/Glycinamide,N-(mercaptoacetyl)-D-tyrosyl-4-(aminoiminomethyl)-L-phenylalanylglycyl-L-a-aspartyl-L-cysteinyl-L-lysylglycyl-L-cysteinyl-,cyclic (1®5)-thioether, (8®1''),(8'®1'')-bis(thioether) withN6-[N2,N6-bis(mercaptoacetyl)-L-lysyl]-L-lysylglycyl-L-cysteinamide (9CI)
- 91782-80-8/Glycine, N-[2-[(2-hydroxyethyl)amino]ethyl]-, N-coco acyl derivs., monosodium salts
- 97732-59-7/2,4-Ethano-4H-indeno[5,6-c]oxeto[3,2-b]furan-8-ol,decahydro-2a,4,5a-trimethyl-8-(1-methylethyl)-,(2R,2aR,4S,4aR,5aR,8R,8aR,9aS)-rel-(+)- (9CI)
- 62008-56-4/2-(3-Methylphenyl)-Morpholine HCl
- 23204-07-1/6-methoxy-4,4-dimethyl-1,2,3,4-tetrahydronaphthalen-2-amine hydrochloride (1:1)
- 34955-25-4/4-(Pyridin-3-yl)-thiosemicarbazide
- 62152-42-5/potassium sodium carbonate hydrogen phosphate (2:4:2:1)
- 63449-91-2/N-(3-thienylmethyl)pyridin-2-amine
- 74131-15-0/ethyl 5-methoxy-2-sulfamoylbenzoate
- 6458-01-1/3-amino-N-(3-chlorobenzyl)-6-(thiophen-2-yl)thieno[2,3-b]pyridine-2-carboxamide
- 28843-63-2/N-(4,5-dichloro-2-{[(3-nitro-6-oxocyclohexa-2,4-dien-1-ylidene)methyl]amino}phenyl)benzenesulfonamide